ANAB · Anaptysbio, Inc

$56.69 -2.57 (-4.34%) At close · Aug 20

Market Cap

$1.65B

29.10M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel Faga	President and Chief Executive Officer and Director	$706,011	—	$1,592,001	$3,345,653	$465,968	$24,310	$6,133,943
Paul Lizzul	Chief Medical Officer	$545,754	—	$505,703	$1,064,476	$221,031	$28,413	$2,365,377
Dennis Mulroy	Chief Financial Officer	$510,070	—	$397,444	$836,687	$224,431	$39,295	$2,007,927

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel Faga	President and Chief Executive Officer and Director	$685,448	—	$6,889,127	$5,723,455	$308,452	$23,810	$13,630,292
Paul Lizzul	Chief Medical Officer	$529,859	—	$2,128,976	$1,741,973	$158,958	$23,742	$4,583,508
Dennis Mulroy	Chief Financial Officer	$495,213	—	$1,196,600	$1,368,672	$148,564	$29,858	$3,238,907

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel Faga	President and Chief Executive Officer and Director	$640,605	—	$1,658,622	$3,287,320	$352,333	$1,523,040	$7,461,920
Paul Lizzul	Chief Medical Officer	$509,479	—	$570,993	$1,131,250	$203,792	$25,603	$2,441,117
Eric Loumeau	Chief Legal Officer	$493,823	—	$515,241	$1,020,941	$197,529	$30,650	$2,258,185
Dennis Mulroy	Chief Financial Officer	$479,393	—	$487,365	$965,787	$191,757	$31,651	$2,155,954

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Daniel Faga	President and Chief Executive Officer and Director	$483,578	—	$23,506,640	$200,618	$240,609	$8,905	$24,440,350
Eric Loumeau	Chief Legal Officer	$474,830	—	$283,440	$2,872,730	$197,648	$13,115	$3,841,763
Paul Lizzul	Chief Medical Officer	$471,740	—	$283,440	$2,872,730	$174,544	$10,074	$3,812,528

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hamza Suria	President, Chief Executive Officer and Director	$586,000	—	—	$2,702,323	$241,725	$8,810	$3,538,858
Paul Lizzul	Chief Medical Officer	$458,000	—	—	$1,015,911	$216,357	$8,810	$1,699,078
Eric Loumeau	Chief Operating Officer and General Counsel	$461,000	—	—	$1,015,911	$168,553	$10,322	$1,655,786

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dennis Mulroy	Chief Financial Officer	$184,872	—	—	$1,358,918	$74,317	$4,746	$1,622,853
Paul Lizzul	Chief Medical Officer	$168,205	—	—	$1,238,769	$67,507	$104,238	$1,578,719
Hamza Suria	President, Chief Executive Officer and Director	$567,000	—	—	—	$311,850	$6,540	$885,390
Eric Loumeau	Chief Operating Officer and General Counsel	$399,025	—	—	$149,991	$168,000	$8,322	$725,338

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hamza Suria	M.B.A. President, Chief Executive Officer and Director	$567,000	—	—	$7,301,646	—	$6,540	$7,875,186
Dominic G. Piscitelli	M.B.A., C.P.A. Former Chief Financial Officer	$310,858	—	—	$1,538,226	—	$6,574	$1,855,658

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hamza Suria	M.B.A. President, Chief Executive Officer and Director	$547,000	—	—	$4,303,927	$270,765	$540	$5,122,232
Marco Londei	Former Chief Medical Officer	$436,000	—	—	$1,912,856	$161,320	$3,564	$2,513,740
Eric Loumeau	Interim Chief Financial Officer and General Counsel	$148,106	—	—	$1,961,388	$54,763	$774	$2,165,031
Dominic G. Piscitelli	M.B.A., C.P.A. Former Chief Financial Officer	$397,000	—	—	$1,571,275	$146,890	$540	$2,115,705

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hamza Suria	M.B.A. President, Chief Executive Officer and Director	$465,000	—	—	$3,341,588	$209,250	$600	$4,016,438
Dominic G. Piscitelli	M.B.A., C.P.A. Former Chief Financial Officer	$356,811	$100,000	—	$2,290,041	$111,143	$13,253	$2,871,248
Marco Londei	Former Chief Medical Officer	$395,250	—	—	$1,633,665	$117,982	$3,960	$2,150,857

Executive changes

Person	Role	Change	Effective	Filed
Owen Hughes	Class I director	Appointed	2026-05-11	2026-05-11
Christopher M. Murphy	Chief Financial Officer	Appointed	2026-05-11	2026-05-11
John Orwin	Chairman of the Board	Appointed	2023-09-15	2023-09-18
James N. Topper, M.D., Ph.D.	Class II director	Resigned	2023-09-15	2023-09-18
John Orwin	Class II director	Appointed	2023-09-15	2023-09-18
James N. Topper, M.D., Ph.D.	Chairman of the Board	Resigned	2023-09-15	2023-09-18
Rita Jain, M.D.	Class II director	Appointed	2023-04-03	2023-04-06
Laura J. Hamill	Class II director	Resigned	2023-04-01	2023-04-06
Eric Loumeau	Chief Operating Officer and General Counsel	Appointed	2022-04-25	2022-04-29
James Topper	Class II Director	Appointed	2022-04-25	2022-04-29
James Topper	Class I Director	Resigned	2022-04-25	2022-04-29
Daniel Faga	Interim President and Chief Executive Officer	Appointed	2022-03-21	2022-03-21
Hamza Suria	Class II director	Resigned	2022-03-20	2022-03-21
Hamza Suria	President and Chief Executive Officer	Resigned	2022-03-20	2022-03-21
Daniel Faga	Class I director	Appointed	2021-11-26	2021-11-29
Oleg Nodelman	Class I director	Appointed	2021-04-08	2021-04-12
Magda Marquet, Ph.D.	Class III director	Appointed	2021-01-18	2021-01-19
Paul F. Lizzul, M.D., Ph.D., M.P.H., M.B.A.	Chief Medical Officer	Appointed	2020-07-31	2020-07-31
Eric Loumeau	Chief Operating Officer	Appointed	2020-07-15	2020-07-15
Dennis Mulroy	Chief Financial Officer	Appointed	2020-07-15	2020-07-15

Key facts CIK 1370053 CUSIP 032724106 13F (30d) 203 filings 200 filers Visit website Investor relations